Product Description
Chemical Name:5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid
- CAS No.1422956-25-9
- Molecular Formula: C28H30N4O3
- Formula Weight:507.032
Synonyms:5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid
AI Product Description
*The following content is generated by AI and is for reference only.
The compound 98% up 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester is a sophisticated organic molecule primarily utilized in advanced medicinal chemistry and pharmaceutical research. While specific commercial catalog listings may vary, this substance generally falls under the category of bioactive small molecules designed for target identification and drug discovery programs. Its structural architecture combines several critical pharmacophores: an indole ring system known for its prevalence in neurotransmitters and alkaloids, a piperazine linker offering conformational flexibility and solubility modulation, a cyano group enhancing metabolic stability or binding affinity, and a benzofuran carboxylic acid ethyl ester moiety which often serves as a scaffold for receptor interaction.
In the realm of scientific inquiry, such compounds are frequently synthesized to investigate their potential as inhibitors or modulators of specific biological targets, including G-protein coupled receptors (GPCRs), ion channels, or kinases involved in oncology, neurodegeneration, or cardiovascular diseases. The presence of the indole core suggests possible interactions with serotonin or dopamine pathways, while the piperazine ring is a common feature in many central nervous system (CNS) active drugs. Researchers utilize high-purity grades, typically exceeding 98%, to ensure reproducible results in vitro and in vivo assays. These studies aim to elucidate structure-activity relationships (SAR), optimizing lead compounds for potency, selectivity, and pharmacokinetic profiles before advancing to preclinical development.
Although not currently a widely marketed consumer product, this chemical entity represents the kind of specialized intermediate or research tool essential for academic laboratories and biotechnology firms developing novel therapeutics. It underscores the complexity of modern drug design, where precise molecular engineering dictates biological outcome. Users handling this material must adhere to strict safety protocols, utilizing appropriate personal protective equipment due to the potential toxicity associated with uncharacterized organic synthesis intermediates. Ultimately, this molecule serves as a vital component in the pipeline of innovation, bridging the gap between theoretical chemical structures and tangible medical solutions for complex human ailments.
![98% up 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester](https://eimg.pharmasources.com/image/20211122/yEVbIgyOWpn2ohNePISQIqjQQok4DnJvi4x1syKM.jpeg)
(All Rights Reserved)
